What is Celularity Inc. (CELU)?
Celularity Inc. is a biotechnology company specializing in the development of allogeneic cell therapies derived from placental and other postpartum tissues. The company focuses on harnessing the potential of placental-derived cells for regenerative medicine and immuno-oncology applications. Its research and development efforts aim to create treatments that address a variety of medical conditions, including cancer, infectious diseases, and degenerative disorders. Celularity's platform leverages the unique properties of placental cells, which are believed to possess regenerative and immune-modulating capabilities. The company operates within the broader field of cellular therapies, which involves the use of living cells to repair or replace damaged tissues and organs. Celularity collaborates with academic institutions and industry partners to advance its scientific programs and clinical trials. Its approach reflects ongoing trends in biotechnology toward developing off-the-shelf, scalable therapies that can be administered to multiple patients without the need for individualized cell harvesting.
Celularity Inc. Stock Price Today: Live Overview
The price today is shaped by trading movements in Celularity Inc., with the current price at $1.2532. It has fluctuated within $1.1668 to $1.3268, reflecting a daily change of 0%.
FAQ: Celularity Inc. (CELU)
What is the current price of CELU stock?
The current price is $1.2532.
Does CELU pay dividends?
Celularity Inc. does not pay dividends.
Does CELU have a formal corporate presence or regional headquarters in the UAE?
The company operates through partners and distributors in the UAE without an official office.
What is CELU best known for?
It is most famous for its cellular therapies and regenerative medicine.
What assets are typically shown together with CELU?
Commonly shown alongside CELU: Omeros Corp, Pluri Inc., Seres Therapeutics Inc
Latest shares articles



